نتایج جستجو برای: ca19

تعداد نتایج: 1202  

ژورنال: :مجله علمی دانشگاه علوم پزشکی بیرجند 0
علی مختاری فر ali mokhtarifar emam reza hospital, deparment of internal medicineبیمارستان امام رضا (ع)، بخش داخلی طاهره فخاریان تربتی tahere fakharian emam reza hospital, deparment of internal medicineمشهد- بیمارستان امام رضا(ع)- دفتر گروه داخلی تلفن: 8593031-0511 الهام مختاری elham mokhtari emam reza hospital, deparment of internal medicineبیمارستان امام رضا (ع)، بخش داخلی

ca19-9 یک آنتی ژن کربوهیدراتی است که کاربردش به طور شایع به عنوان نشانگر سرمی تومور در بدخیمی های پانکراس و مجاری صفراوی افزایش می یابد. حساسیت ca19-9 در تشخیص بدخیمی پانکراس،70 تا 90 درصد و وی‍ژگی، 68 تا 91 درصد می باشد. افزایش ca19-9 در موارد دیگری از جمله سایر بدخیمی ها و برخی وضعیت های خوش خیم مانند انسداد مجاری صفراوی، به علل دیگر از جمله سنگ نیز دیده می شود اما در این موارد افزایش، قابل ت...

2016
E. G. Chiorean D. D. Von Hoff M. Reni F. P. Arena J. R. Infante V. G. Bathini T. E. Wood P. N. Mainwaring R. T. Muldoon P. R. Clingan V. Kunzmann R. K. Ramanathan J. Tabernero D. Goldstein D. McGovern B. Lu A. Ko

BACKGROUND A phase I/II study and subsequent phase III study (MPACT) reported significant correlations between CA19-9 decreases and prolonged overall survival (OS) with nab-paclitaxel plus gemcitabine (nab-P + Gem) treatment for metastatic pancreatic cancer (MPC). CA19-9 changes at week 8 and potential associations with efficacy were investigated as part of an exploratory analysis in the MPACT ...

Journal: :Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2012
Koichiro Tsutsumi Hirofumi Kawamoto Ken Hirao Ichiro Sakakihara Naoki Yamamoto Yasuhiro Noma Masakuni Fujii Hironari Kato Tsuneyoshi Ogawa Etsuji Ishida Kenji Kuwaki Kazuhiro Nouso Hiroyuki Okada Kazuhide Yamamoto

BACKGROUND Measurement of objective response to chemotherapy using imaging modalities is sometimes difficult in pancreatic cancer (PC). We aimed to verify whether monitoring of serum tumor markers (TMs), namely carcinoembryonic antigen, CA19-9, DUPAN-2, SPan-1, can facilitate earlier confirmation of treatment failure. METHODS Monitoring of serum TMs and computed tomography were performed ever...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2015
Darragh P O'Brien Neomal S Sandanayake Claire Jenkinson Aleksandra Gentry-Maharaj Sophia Apostolidou Evangelia-Ourania Fourkala Stephane Camuzeaux Oleg Blyuss Richard Gunu Anne Dawnay Alexey Zaikin Ross C Smith Ian J Jacobs Usha Menon Eithne Costello Stephen P Pereira John F Timms

PURPOSE Biomarkers for the early detection of pancreatic cancer are urgently needed. The primary objective of this study was to evaluate whether increased levels of serum CA19-9, CA125, CEACAM1, and REG3A are present before clinical presentation of pancreatic cancer and to assess the performance of combined markers for early detection and prognosis. EXPERIMENTAL DESIGN This nested case-contro...

2016
Yawen Deng Rihui Zhong Xiaoying Xie Xuxia Xiong Jian He Linhui Peng Hua Zeng Chaohui Duan

Background: Aims serum markers provide a non-invasive, cheap and effective diagnostic and prognostic tool for cholangiocarcinoma. In this study, we aimed to evaluate serum levels of CEA, CA125, CA19-9 and CA724 for the diagnosis and staging of cholangiocarcinoma. Materials and methods: Serum levels of CA125, CA19-9, CA724 and CEA were measured preoperatively, postoperatively and during follow-u...

2011
Xin Guo Sohsuke Yamada Haruki Omori Ke-Yong Wang Takashi Tasaki Atsunori Nabeshima Kimitoshi Kohno Yasuyuki Sasaguri

Here we report the first case of carbohydrate antigen (CA) 19-9-producing early gastric adenocarcinoma arising in polyp. A solitary pedunculated polyp lesion of the stomach, measuring 26 × 20 × 20 mm, was noticed in a 76-year-old Japanese woman due to an abdominal disorder, associated with a markedly high serum CA19-9 level (2,172.6 U/ml). After endoscopic mucosal resection was performed, the C...

Journal: :HPB : the official journal of the International Hepato Pancreato Biliary Association 2001
M J Midwinter A Watson V Wadehra R M Charnley

BACKGROUND Free tumour cells in the peritoneal cavity of patients with pancreatic carcinoma carry a poor prognosis. Reactive or degenerative mesothelial cells can make cytological interpretation with conventional stains difficult. Detection of the tumour-associated antigens carcinoembryonic antigen (CEA) and CA19-9 may improve detection. METHODS At staging laparoscopy, 22 patients with pancre...

Journal: :International journal of clinical and experimental pathology 2015
Jingtao Wang Xiao Wang Fudong Yu Jian Chen Senlin Zhao Dongyuan Zhang Yang Yu Xisheng Liu Huamei Tang Zhihai Peng

We assessed the prognostic significance of preoperative serum carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9) and carbohydrate antigen 242 (CA242) levels in surgically treated colorectal cancer patients. The relationship of preoperative serum CEA, CA19-9 and CA242 levels with disease characteristics was investigated in 310 patients. Correlation between tumor markers was inves...

Journal: :American journal of physiology. Gastrointestinal and liver physiology 2001
N Sreejayan B M Wittig N von Stillfried M S Hennicke G Meyer P Stieber R Lamerz C von Ritter

E-selectin, expressed on endothelial cells, mediates adhesion of leukocytes and tumor cells to endothelium. CA19-9 (sialyl-Lewis(a)) and sialyl-Lewis(x) are specific ligands for E-selectin. We have recently shown that mucin-rich culture media from human gallbladder epithelial cells contains CA19-9. In this study, we have tested whether human biliary mucin binds to E-selectin. The ability of muc...

2017
Chang Jiang Shousheng Liu Wenzhuo He Bei Zhang Liangping Xia

Objective: We had previously demonstrated that the carbohydrate antigen 19-9 (CA19-9), lactate dehydrogenase (LDH), neutrophil lymphocyte ratio (NLR) are prognostic factors for patients with metastatic colorectal cancer (mCRC). In this study, we try to analysis the association of these blood-based biomarkers with bevacizumab efficacy in the first line setting. Methods: A total of 284 eligible c...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید